SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

17 May 2023 07:00

RNS Number : 6426Z
TP ICAP Group plc
17 May 2023
 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

 

17 May 2023

 

Trading update for the three months ended 31 March 2023

 

 

Revenue performance (in constant currency, unless in brackets, which denotes reported currency)

 

Total Group revenue of £606m up 2% (+9% in reported currency). Global Broking revenue up 3% (+9%). All asset classes generated low to mid-single digit growth. In Energy & Commodities (E&C), revenue increased by 3% (+10%), in line with exchange volumes. Market conditions, and liquidity, in European Gas & Power continued to improve, leading to an increase in revenue. Revenue in Oil was unchanged. There was a strong comparative period last year for Global Broking and E&C.

 

Parameta Solutions revenue grew by 7% (+15%). The division continues to target double-digit constant currency growth in Adjusted EBIT. Liquidnet division revenue was down 3% (+3%). There was a strong performance from the relative value business, while cash equities revenue declined in line with block market volumes.

 

We remain well positioned and expect interest rates to remain at elevated levels throughout the year; at the same time, the benefit of the recent strong US Dollar is now moderating.

 

Strategic update

 

· Good momentum on connecting major US banks - a key strategic deliverable - to Liquidnet's Dealer-to-Client Credit platform, which offers clients a range of services: Request-For-Quote (RFQ), Rebalance, and e-Repo. One large US bank is now directly connected to our API on the RFQ protocol. A second large US bank is in the final stages of certification;

· Parameta Solutions approved as an ESMA-authorised benchmark administrator: the first data provider to administer OTC benchmarks and indices across Europe/UK;

· The Group successfully completed a new £250m bond issuance on 5 April to refinance the existing January 2024 bond. The new issue was more than 5x over-subscribed.

 

 

2023 Annual General Meeting

 

The Group will host its Annual General Meeting today, Wednesday 17 May 2023, at 2.15pm (BST) at the offices of Allen & Overy LLP, One Bishop's Square, London, E1 6AD.

 

 

2023 half year results

 

The Group will report its results for the six months ended 30 June 2023 on 9 August 2023.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Group. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Group's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries:

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Group's website: www.tpicap.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTEIIRLIV
Date   Source Headline
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change
13th Dec 20189:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.